The year in cardiothoracic and vascular anesthesia: Selected highlights from 2010

Michael Andritsos, Nina Singh, Prakash Patel, Ashish Sinha, Jens Fassl, Tygh Wyckoff, Hynek Riha, Chris Roscher, Balachundar Subramaniam, Harish Ramakrishna, John G T Augoustides

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The aortic valve treatment revolution continues with the maturation of aortic valve repair and the dissemination of transcatheter aortic valve implantation. The recent publication of comprehensive multidisciplinary guidelines for diseases of the thoracic aorta has assigned important roles for the cardiovascular anesthesiologist and perioperative echocardiographer. Although intense angiotensin blockade improves outcomes in heart failure, it might further complicate the maintenance of perioperative systemic vascular tone. Ultrafiltration as well as intensive medical management guided by the biomarker brain natriuretic peptide improves outcomes in heart failure. Continuous-flow left ventricular assist devices have further improved outcomes in the surgical management of heart failure. Major risk factors for bleeding in the setting of these devices include advanced liver disease and acquired von Willebrand syndrome. The metabolic modulator perhexiline improves myocardial diastolic energetics to achieve significant symptomatic improvement in hypertrophic cardiomyopathy. A landmark report was also published recently that outlines the major areas for future research and clinical innovation in this disease. Landmark trials have documented the outcome importance of perioperative cerebral oxygen saturation monitoring as well as the outcome advantages of the Sano shunt over the modified Blalock-Taussig shunt in the Norwood procedure. Furthermore, the development and evaluation of pediatric-specific ventricular assist devices likely will revolutionize the mechanical management of pediatric heart failure. A multidisciplinary review has highlighted the priorities for future perioperative trials in congenital heart disease. These pervasive developments likely will influence the future training models in pediatric cardiac anesthesia.

Original languageEnglish (US)
Pages (from-to)6-15
Number of pages10
JournalJournal of Cardiothoracic and Vascular Anesthesia
Volume25
Issue number1
DOIs
StatePublished - Feb 2011

Fingerprint

Blood Vessels
Anesthesia
Heart Failure
Heart-Assist Devices
Pediatrics
Aortic Valve
Perhexiline
Norwood Procedures
Blalock-Taussig Procedure
Brain Natriuretic Peptide
Hypertrophic Cardiomyopathy
Angiotensins
Ultrafiltration
Thoracic Aorta
Liver Diseases
Heart Diseases
Biomarkers
Maintenance
Guidelines
Hemorrhage

Keywords

  • angiotensin
  • aortic aneurysm
  • aortic dissection
  • aortic valve
  • aortic valve repair
  • Blalock-Taussig shunt
  • cerebral oxygen saturation
  • congenital heart disease
  • endovascular aortic repair
  • guidelines
  • heart failure
  • hypertrophic cardiomyopathy
  • metabolic modulator
  • model for end-stage liver disease
  • natriuretic peptide
  • near-infrared
  • Norwood procedure
  • perhexiline
  • perioperative management
  • Sano shunt
  • spectroscopy
  • thoracic aorta
  • transcatheter aortic valve implantation
  • ultrafiltration
  • ventricular assist device
  • von Willebrand syndrome

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Anesthesiology and Pain Medicine

Cite this

Andritsos, M., Singh, N., Patel, P., Sinha, A., Fassl, J., Wyckoff, T., ... Augoustides, J. G. T. (2011). The year in cardiothoracic and vascular anesthesia: Selected highlights from 2010. Journal of Cardiothoracic and Vascular Anesthesia, 25(1), 6-15. https://doi.org/10.1053/j.jvca.2010.11.001

The year in cardiothoracic and vascular anesthesia : Selected highlights from 2010. / Andritsos, Michael; Singh, Nina; Patel, Prakash; Sinha, Ashish; Fassl, Jens; Wyckoff, Tygh; Riha, Hynek; Roscher, Chris; Subramaniam, Balachundar; Ramakrishna, Harish; Augoustides, John G T.

In: Journal of Cardiothoracic and Vascular Anesthesia, Vol. 25, No. 1, 02.2011, p. 6-15.

Research output: Contribution to journalArticle

Andritsos, M, Singh, N, Patel, P, Sinha, A, Fassl, J, Wyckoff, T, Riha, H, Roscher, C, Subramaniam, B, Ramakrishna, H & Augoustides, JGT 2011, 'The year in cardiothoracic and vascular anesthesia: Selected highlights from 2010', Journal of Cardiothoracic and Vascular Anesthesia, vol. 25, no. 1, pp. 6-15. https://doi.org/10.1053/j.jvca.2010.11.001
Andritsos, Michael ; Singh, Nina ; Patel, Prakash ; Sinha, Ashish ; Fassl, Jens ; Wyckoff, Tygh ; Riha, Hynek ; Roscher, Chris ; Subramaniam, Balachundar ; Ramakrishna, Harish ; Augoustides, John G T. / The year in cardiothoracic and vascular anesthesia : Selected highlights from 2010. In: Journal of Cardiothoracic and Vascular Anesthesia. 2011 ; Vol. 25, No. 1. pp. 6-15.
@article{32a1b22a7ab44e33b3e2771a3750e773,
title = "The year in cardiothoracic and vascular anesthesia: Selected highlights from 2010",
abstract = "The aortic valve treatment revolution continues with the maturation of aortic valve repair and the dissemination of transcatheter aortic valve implantation. The recent publication of comprehensive multidisciplinary guidelines for diseases of the thoracic aorta has assigned important roles for the cardiovascular anesthesiologist and perioperative echocardiographer. Although intense angiotensin blockade improves outcomes in heart failure, it might further complicate the maintenance of perioperative systemic vascular tone. Ultrafiltration as well as intensive medical management guided by the biomarker brain natriuretic peptide improves outcomes in heart failure. Continuous-flow left ventricular assist devices have further improved outcomes in the surgical management of heart failure. Major risk factors for bleeding in the setting of these devices include advanced liver disease and acquired von Willebrand syndrome. The metabolic modulator perhexiline improves myocardial diastolic energetics to achieve significant symptomatic improvement in hypertrophic cardiomyopathy. A landmark report was also published recently that outlines the major areas for future research and clinical innovation in this disease. Landmark trials have documented the outcome importance of perioperative cerebral oxygen saturation monitoring as well as the outcome advantages of the Sano shunt over the modified Blalock-Taussig shunt in the Norwood procedure. Furthermore, the development and evaluation of pediatric-specific ventricular assist devices likely will revolutionize the mechanical management of pediatric heart failure. A multidisciplinary review has highlighted the priorities for future perioperative trials in congenital heart disease. These pervasive developments likely will influence the future training models in pediatric cardiac anesthesia.",
keywords = "angiotensin, aortic aneurysm, aortic dissection, aortic valve, aortic valve repair, Blalock-Taussig shunt, cerebral oxygen saturation, congenital heart disease, endovascular aortic repair, guidelines, heart failure, hypertrophic cardiomyopathy, metabolic modulator, model for end-stage liver disease, natriuretic peptide, near-infrared, Norwood procedure, perhexiline, perioperative management, Sano shunt, spectroscopy, thoracic aorta, transcatheter aortic valve implantation, ultrafiltration, ventricular assist device, von Willebrand syndrome",
author = "Michael Andritsos and Nina Singh and Prakash Patel and Ashish Sinha and Jens Fassl and Tygh Wyckoff and Hynek Riha and Chris Roscher and Balachundar Subramaniam and Harish Ramakrishna and Augoustides, {John G T}",
year = "2011",
month = "2",
doi = "10.1053/j.jvca.2010.11.001",
language = "English (US)",
volume = "25",
pages = "6--15",
journal = "Journal of Cardiothoracic and Vascular Anesthesia",
issn = "1053-0770",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - The year in cardiothoracic and vascular anesthesia

T2 - Selected highlights from 2010

AU - Andritsos, Michael

AU - Singh, Nina

AU - Patel, Prakash

AU - Sinha, Ashish

AU - Fassl, Jens

AU - Wyckoff, Tygh

AU - Riha, Hynek

AU - Roscher, Chris

AU - Subramaniam, Balachundar

AU - Ramakrishna, Harish

AU - Augoustides, John G T

PY - 2011/2

Y1 - 2011/2

N2 - The aortic valve treatment revolution continues with the maturation of aortic valve repair and the dissemination of transcatheter aortic valve implantation. The recent publication of comprehensive multidisciplinary guidelines for diseases of the thoracic aorta has assigned important roles for the cardiovascular anesthesiologist and perioperative echocardiographer. Although intense angiotensin blockade improves outcomes in heart failure, it might further complicate the maintenance of perioperative systemic vascular tone. Ultrafiltration as well as intensive medical management guided by the biomarker brain natriuretic peptide improves outcomes in heart failure. Continuous-flow left ventricular assist devices have further improved outcomes in the surgical management of heart failure. Major risk factors for bleeding in the setting of these devices include advanced liver disease and acquired von Willebrand syndrome. The metabolic modulator perhexiline improves myocardial diastolic energetics to achieve significant symptomatic improvement in hypertrophic cardiomyopathy. A landmark report was also published recently that outlines the major areas for future research and clinical innovation in this disease. Landmark trials have documented the outcome importance of perioperative cerebral oxygen saturation monitoring as well as the outcome advantages of the Sano shunt over the modified Blalock-Taussig shunt in the Norwood procedure. Furthermore, the development and evaluation of pediatric-specific ventricular assist devices likely will revolutionize the mechanical management of pediatric heart failure. A multidisciplinary review has highlighted the priorities for future perioperative trials in congenital heart disease. These pervasive developments likely will influence the future training models in pediatric cardiac anesthesia.

AB - The aortic valve treatment revolution continues with the maturation of aortic valve repair and the dissemination of transcatheter aortic valve implantation. The recent publication of comprehensive multidisciplinary guidelines for diseases of the thoracic aorta has assigned important roles for the cardiovascular anesthesiologist and perioperative echocardiographer. Although intense angiotensin blockade improves outcomes in heart failure, it might further complicate the maintenance of perioperative systemic vascular tone. Ultrafiltration as well as intensive medical management guided by the biomarker brain natriuretic peptide improves outcomes in heart failure. Continuous-flow left ventricular assist devices have further improved outcomes in the surgical management of heart failure. Major risk factors for bleeding in the setting of these devices include advanced liver disease and acquired von Willebrand syndrome. The metabolic modulator perhexiline improves myocardial diastolic energetics to achieve significant symptomatic improvement in hypertrophic cardiomyopathy. A landmark report was also published recently that outlines the major areas for future research and clinical innovation in this disease. Landmark trials have documented the outcome importance of perioperative cerebral oxygen saturation monitoring as well as the outcome advantages of the Sano shunt over the modified Blalock-Taussig shunt in the Norwood procedure. Furthermore, the development and evaluation of pediatric-specific ventricular assist devices likely will revolutionize the mechanical management of pediatric heart failure. A multidisciplinary review has highlighted the priorities for future perioperative trials in congenital heart disease. These pervasive developments likely will influence the future training models in pediatric cardiac anesthesia.

KW - angiotensin

KW - aortic aneurysm

KW - aortic dissection

KW - aortic valve

KW - aortic valve repair

KW - Blalock-Taussig shunt

KW - cerebral oxygen saturation

KW - congenital heart disease

KW - endovascular aortic repair

KW - guidelines

KW - heart failure

KW - hypertrophic cardiomyopathy

KW - metabolic modulator

KW - model for end-stage liver disease

KW - natriuretic peptide

KW - near-infrared

KW - Norwood procedure

KW - perhexiline

KW - perioperative management

KW - Sano shunt

KW - spectroscopy

KW - thoracic aorta

KW - transcatheter aortic valve implantation

KW - ultrafiltration

KW - ventricular assist device

KW - von Willebrand syndrome

UR - http://www.scopus.com/inward/record.url?scp=79251567340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251567340&partnerID=8YFLogxK

U2 - 10.1053/j.jvca.2010.11.001

DO - 10.1053/j.jvca.2010.11.001

M3 - Article

C2 - 21272776

AN - SCOPUS:79251567340

VL - 25

SP - 6

EP - 15

JO - Journal of Cardiothoracic and Vascular Anesthesia

JF - Journal of Cardiothoracic and Vascular Anesthesia

SN - 1053-0770

IS - 1

ER -